Skip to content

VARMAM THERAPY WITH AND WITHOUT KURUNTHOTTI KASHAYAM for the CEGANAVATHAM (CERVICAL SPONDYLOSIS)

A PRECLINICAL AND COMPARATIVE CLINICAL TRIAL OF VARMAM THERAPY WITH AND WITHOUT KURUNTHOTTI KASHAYAM (INTERNALLY) IN THE MANAGEMENT OF CEGANAVATHAM (CERVICAL SPONDYLOSIS)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029368
Enrollment
40
Registered
2020-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: Varmam therapy and kurunthotti kashayam: varmam therapy-48 days weekly thrice( 21 sittings) kurunthotti kashayam - 3 days (6o ml twice a day) Control Intervention1: varmam therapy comp

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pain present behind the neck Region, aggravated by movement 2. Neck stiffness 3. Difficulty in flexion and extension of neck 4.pain radiating to shoulder blade, top of the shoulder, upper arm and back of the head 5. Dizziness or vertigo 6. Numbness in both upper limb 4. Pain radiating to

Exclusion criteria

Exclusion criteria: 1. Patient with uncontrolled hypertension 2.pregancy and lactation 3. Cervical rib 4. Spina bifida 5. Ankylosis spondylosis 6. Rheumatoid arthritis 7. Patient with thyroid 8. Any trauma history 9. Loss of bowel and bladder control 10. Dysphagia 11. Fracture in neck region 12. Coronary artery disease 13. Tuberculosis 14. Severe osteoporosis 15. Neck surgery

Design outcomes

Primary

MeasureTime frame
UNIVERSAL PAIN ASSESSMENT SCALETimepoint: 48 days

Secondary

MeasureTime frame
To study the siddha basic principles relevant to the diseasesTimepoint: 48 days

Countries

India

Contacts

Public ContactDr Mahadevan V

National Institute of Siddha

mahasiddha2009@gmail.com9840417565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026